サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541043

核酸検査市場レポート：製品タイプ、技術、エンドユーザー、地域別、2024～2032年

Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
核酸検査市場レポート：製品タイプ、技術、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核酸検査市場規模は2023年に30億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに51億米ドルに達し、2024～2032年の間に5.7%の成長率（CAGR）を示すと予測しています。

核酸検査（NAT）とは、患者の血液、組織、尿中のウイルス、細菌、病原性核酸をスクリーニングする分子技術を指します。法医学的検査や輸血感染症、遺伝病、がんの診断のために実施されます。核酸（NA）抽出、標的NA増幅、標的アンプリコンNA検出によるサンプルプールが含まれます。検査には、ポリメラーゼ連鎖反応（PCR）、鎖置換増幅（SDA）、リガーゼ連鎖反応（LCR）、転写媒介増幅（TMA）、NA配列別の増幅（NASBA）プロセスを実施するためのキットや消耗品が含まれます。NATはまた、目に見える症状のない疾患の同定や偽反応性解釈の解決にも使用されます。

世界中で感染性細菌とウイルス性疾患の流行が増加していることは、市場の成長を促進する主要要因の1つです。さらに、高度な診断システムに対する需要の高まりも市場の成長を後押ししています。これに伴い、コロナウイルス病（COVID-19）の発症も、抗原を検出するNATソリューションの需要を高めています。NATは、感染症の効果的な管理や感染源の正確な特定に広く使用されています。さらに、シグナルやプローブの増幅システムを含む新しい生物学的診断技術の開発など、様々な技術的進歩が他の成長促進要因として作用しています。これらの革新的な技術は、病気の早期発見やウイルスの感染期間の最小化に役立っています。その他の要因としては、広範な研究開発（R&D）活動、医療インフラの改善などがあり、市場をさらに牽引すると予想されます。

本レポートで扱う主要質問

  • 世界の核酸検査市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19は世界の核酸検査市場にどのような影響を与えたか？
  • 主要地域市場とは？
  • 製品タイプ別の市場内訳は？
  • 技術別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の核酸検査市場の構造と主要参入企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の核酸検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 機器
  • 試薬と消耗品

第7章 市場内訳：技術別

  • TMA-転写介在増幅
  • PCR-ポリメラーゼ連鎖反応
  • LCR-リガーゼ連鎖反応
  • SDA-鎖置換増幅
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院とクリニック
  • 病理学研究所
  • 研究機関
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Merck KGaA
    • Siemens Healthcare
    • Tecan Group AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Nucleic Acid Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Nucleic Acid Testing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Nucleic Acid Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Nucleic Acid Testing Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Nucleic Acid Testing Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Nucleic Acid Testing Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Nucleic Acid Testing Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Nucleic Acid Testing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Nucleic Acid Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Nucleic Acid Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Nucleic Acid Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Nucleic Acid Testing (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Nucleic Acid Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Nucleic Acid Testing (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Nucleic Acid Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Nucleic Acid Testing (Pathology Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Nucleic Acid Testing (Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Nucleic Acid Testing (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Nucleic Acid Testing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Nucleic Acid Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Nucleic Acid Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia-Pacific: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Nucleic Acid Testing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Nucleic Acid Testing Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Nucleic Acid Testing Industry: SWOT Analysis
  • Figure 80: Global: Nucleic Acid Testing Industry: Value Chain Analysis
  • Figure 81: Global: Nucleic Acid Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nucleic Acid Testing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Nucleic Acid Testing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Nucleic Acid Testing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Nucleic Acid Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Nucleic Acid Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Nucleic Acid Testing Market: Competitive Structure
  • Table 7: Global: Nucleic Acid Testing Market: Key Players
目次
Product Code: SR112024A2902

The global nucleic acid testing market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and resolving false reactive interpretations.

The increasing prevalence of infectious bacterial and viral diseases across the globe represents one of the key factors driving the growth of the market. Furthermore, the increasing demand for advanced diagnostic systems is also driving the market growth. In line with this, the onset of the coronavirus disease (COVID-19) has also enhanced the demand for NAT solutions to detect the antigens. NAT is widely used for the effective management of communicable diseases and accurate identification of the infecting agent. Additionally, various technological advancements, such as the development of novel biological diagnostic techniques, including signal and probe amplification systems, are acting as other growth-inducing factors. These innovative techniques aid in the early detection of the disease and minimizing the infectious period of the virus. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nucleic acid testing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, technology and end user.

Breakup by Product Type:

Instruments

Reagents and Consumables

Breakup by Technology:

TMA- Transcription-mediated Amplification

PCR- Polymerase Chain Reaction

LCR- Ligase Chain Reaction

SDA- Strand Displacement Amplification

Others

Breakup by End User:

Hospitals and Clinics

Pathology Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, Siemens Healthcare, Tecan Group AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global nucleic acid testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleic acid testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleic acid testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nucleic Acid Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 TMA- Transcription-mediated Amplification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR- Polymerase Chain Reaction
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 LCR- Ligase Chain Reaction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 SDA- Strand Displacement Amplification
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pathology Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton, Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthcare
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tecan Group AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis